September 18, 2023 — Anthos Therapeutics, Inc., a clinical stage company developing innovative therapies for cardiovascu ...
Atrial Fibrillation
This channel includes news and new technology innovations for the treatment of atrial fibrillation, also referred to as AF or afib. AF is a cardiac arrhythmia caused by irregular and often rapid heart rate. It is caused by the upper chambers (the atria) beating irregularly and uncoordinated with the lower ventricle chambers of of the heart. Symptoms include weakness with heart palpitations and shortness of breath. The conditional can lead to an increased risk of stroke and heart failure. AF episodes can cause the blood in the atria to stagnate and form clots, usually within the left atrial appendage (LAA). The clots can flow to the brain and cause a stroke. Treatments include anticoagulation therapy to dissolve clots, catheter or surgical ablation and LAA occlusion.
September 5, 2023 — The Ohio State University Wexner Medical Center randomized the first patient in the world in a ...
August 31, 2023 — Atrial fibrillation ablation is associated with lower rates of death, urgent heart transplantation or ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
August 24, 2023 — GE HealthCare announces the launch of CardioVisio for Atrial Fibrillation (AFib), a digital tool ...
August 23, 2023 — Atrial fibrillation, or AFib , is the most common heart rhythm problem, affecting millions of ...
August 22, 2023 — A study in more than 15,000 people has found that physical fitness is linked with a lower likelihood ...
For over a decade, the cardiac cryoablation industry has seen little in the way of technological advancements. Yet ...
August 22, 2023 — Recognizing and acting on heart attack symptoms is linked with faster life-saving treatment, according ...
August 7, 2023 — Movano Health, a purpose-driven healthcare solutions company at the intersection of medical and ...
August 7, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson M ...
In the United States, the options currently available for cardiac ablation use thermal mechanisms to ablate tissue and ...
July 21, 2023 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...
July 19, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...
July 7, 2023 — Atrial fibrillation (AFib) is the most common type of heart arrhythmia. This serious condition occurs ...
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The ...
June 30, 2023 — Women with atrial fibrillation progress more rapidly to cognitive impairment and dementia than men with ...
June 14, 2023 — Bayer announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for ...
The global cardiovascular diagnostic and monitoring devices market was valued at $14.2B in 2021 and is projected to ...